Smith Hunter C bought RYTM

July 7, 2025 · Form 4 insider transaction

Smith Hunter C bought 6,986 shares of Rhythm Pharmaceuticals, Inc. at $6.88 per share, a transaction worth $48.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.